| Item Type | Name |
|
Academic Article
|
Measuring the course of anxiety in women giving birth by caesarean section: a prospective study.
|
|
Academic Article
|
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7).
|
|
Academic Article
|
Comparing the course of anxiety in women receiving their first or repeated caesarean section: A prospective cohort study.
|
|
Academic Article
|
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.
|
|
Academic Article
|
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer.
|
|
Academic Article
|
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study.
|
|
Academic Article
|
Predictors of Impaired Postpartum Renal Function in Women after Preeclampsia: Results of a Prospective Single Center Study.
|
|
Academic Article
|
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients.
|
|
Academic Article
|
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.
|
|
Academic Article
|
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
|
|
Academic Article
|
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial.
|
|
Academic Article
|
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial.
|
|
Academic Article
|
Perioperative anxiety and length of hospital stay after caesarean section - A cohort study.
|
|
Academic Article
|
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45?years of age compared to women 16-26?years of age: An open-label phase 3 study.
|
|
Academic Article
|
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2- breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046.
|
|
Academic Article
|
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.
|
|
Academic Article
|
The influence of maternal singing on well-being, postpartum depression and bonding - a randomised, controlled trial.
|
|
Academic Article
|
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma.
|
|
Academic Article
|
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Postpartum Period
|
|
Concept
|
Preoperative Period
|
|
Concept
|
Postoperative Period
|
|
Concept
|
Phase Transition
|
|
Concept
|
Perioperative Period
|
|
Academic Article
|
Selective Adhesion and Switchable Release of Breast Cancer Cells via Hyaluronic Acid Functionalized Dual Stimuli-Responsive Microgel Films.
|
|
Academic Article
|
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041).
|
|
Academic Article
|
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
|
Back to Search Results
